Apotheek de Jonghe SRL
Apotheek de Jonghe reported total assets of €1.13m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 May 2026).
The score of Apotheek de Jonghe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek de Jonghe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
Apotheek de Jonghe's financial analysis
- Solvency90.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek de Jonghe
Apotheek de Jonghe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0407.043.573
- VAT number
- BE0407043573
- Peppol
- Registered · 0208:0407043573 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jan 1970
- Registered office
- 2830 Willebroek
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek de Jonghe (SRL) has been based in Willebroek since 1970, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 217,264 € and equity of €1.01m; its revenue is not published. Its solvency stands at 90.0%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek de Jonghe
Companies in the same business, of comparable size and area, outside its group.
- Apoteek Rooyackers Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.12m
- Pharmacie du Petit Courcelles Retail sale of pharmaceutical products Courcelles · balance sheet €1.64m
- 4Fonteinen Retail sale of pharmaceutical products Machelen (Brab.) · balance sheet €1.12m
- Beirnaert Farma Retail sale of pharmaceutical products Destelbergen · balance sheet €1.13m
- LB Farma Retail sale of pharmaceutical products Kasterlee · balance sheet €1.13m
- Meta Invest & Consult Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- Bio-Homeopharma Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- Van der Vennet Apotheek Retail sale of pharmaceutical products Ghent · balance sheet €1.14m
Frequently asked questions about Apotheek de Jonghe
What is the revenue of Apotheek de Jonghe?
Apotheek de Jonghe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek de Jonghe?
In Belgium, the VAT number is the company number prefixed with BE: BE0407043573 for Apotheek de Jonghe, if the company is VAT-registered. Its company number (CBE) is 0407.043.573.
Where is the registered office of Apotheek de Jonghe?
According to the CBE register, the registered office of Apotheek de Jonghe is in 2830 Willebroek.
What is the equity of Apotheek de Jonghe?
At the close of the 2025 financial year, the equity of Apotheek de Jonghe amounts to 1,012,348 €, a solvency of 90.0% of total assets.
Who manages Apotheek de Jonghe?
The register lists 1 active mandates at Apotheek de Jonghe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek de Jonghe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →